CAPLIPOINT
Invest with MTF
Invest Now
Invest in Caplin Point Laboratories with 3.11X leverage
Caplin Point Laboratories live price: ₹1662.2. It opened at ₹1,690 vs previous close ₹1,688; intraday high/low: ₹1,690/₹1,656. The 50 & 200 DMA stand at ₹1,759.21/₹1,903.18.
Caplin Point Laboratories Performance
- Low
- ₹1,656
- High
- ₹1,690
- 52 Week Low
- ₹1,599
- 52 Week High
- ₹2,395
- Open Price₹1,690
- Previous Close₹1,688
- Volume64,757
- 50 DMA₹1,759.21
- 100 DMA₹1,835.31
- 200 DMA₹1,903.18
Investment Returns
- Over 1 Month -4.3%
- Over 3 Month -15.36%
- Over 6 Month -25.98%
- Over 1 Year -10.4%
Smart Investing Starts Here Start SIP with Caplin Point Laboratories for Steady Growth!
Caplin Point Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.6
- PEG Ratio
- 1.1
- Market Cap Cr
- 12,635
- P/B Ratio
- 3.8
- Average True Range
- 43.78
- EPS
- 80.74
- Dividend Yield
- 0.4
- MACD Signal
- -30.08
- RSI
- 38.3
- MFI
- 33.65
Caplin Point Laboratories Financials
Caplin Point Laboratories Technicals
EMA & SMA
Current Price
₹1,662.20
-25.4
(-1.51%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,700.75
- 50 Day
- ₹1,759.21
- 100 Day
- ₹1,835.31
- 200 Day
- ₹1,903.18
Resistance and Support
1669.4
- R3 1,716.80
- R2 1,703.40
- R1 1,682.80
- S1 1,648.80
- S2 1,635.40
- S3 1,614.80
Caplin Point Laboratories Corporate Actions - Bonus, Splits, Dividends
Caplin Point Laboratories F&O
About Caplin Point Laboratories
- NSE Symbol
- CAPLIPOINT
- BSE Symbol
- 524742
- Managing Director
- Dr. Sridhar Ganesan
- ISIN
- INE475E01026
Similar Stocks to Caplin Point Laboratories
Caplin Point Laboratories FAQs
Caplin Point Laboratories share price is ₹1,662 As on 13 March, 2026 | 18:22
The Market Cap of Caplin Point Laboratories is ₹12634.7 Cr As on 13 March, 2026 | 18:22
The P/E ratio of Caplin Point Laboratories is 20.6 As on 13 March, 2026 | 18:22
The PB ratio of Caplin Point Laboratories is 3.8 As on 13 March, 2026 | 18:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.